BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 15469395)

  • 1. Novel targets for the treatment of endometriosis.
    Nothnick WB
    Expert Opin Ther Targets; 2004 Oct; 8(5):459-71. PubMed ID: 15469395
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endometriosis: in search of optimal treatment.
    Nothnick WB
    Minerva Ginecol; 2010 Feb; 62(1):17-31. PubMed ID: 20186112
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Future targets in endometriosis treatment: targeting the endometriotic implant.
    Nothnick WB; Zhang X
    Mini Rev Med Chem; 2009 Mar; 9(3):324-8. PubMed ID: 19275725
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Emerging drugs for endometriosis.
    Fedele L; Berlanda N
    Expert Opin Emerg Drugs; 2004 May; 9(1):167-77. PubMed ID: 15155142
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New medical treatments for endometriosis.
    Olive DL; Lindheim SR; Pritts EA
    Best Pract Res Clin Obstet Gynaecol; 2004 Apr; 18(2):319-28. PubMed ID: 15157645
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Medical management of endometriosis: novel targets and approaches towards the development of future treatment regimes.
    Nothnick WB; D'Hooghe TM
    Gynecol Obstet Invest; 2003; 55(4):189-98. PubMed ID: 12904691
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New drugs in development for the treatment of endometriosis.
    Fedele L; Somigliana E; Frontino G; Benaglia L; Vigano P
    Expert Opin Investig Drugs; 2008 Aug; 17(8):1187-202. PubMed ID: 18616415
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dienogest compared with gonadotropin-releasing hormone agonist after conservative surgery for endometriosis.
    Takaesu Y; Nishi H; Kojima J; Sasaki T; Nagamitsu Y; Kato R; Isaka K
    J Obstet Gynaecol Res; 2016 Sep; 42(9):1152-8. PubMed ID: 27225336
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinical study on the effectiveness and safety of combined laparoscopy and gonadotropin-releasing hormone agonist in the treatment of endometriosis].
    Song JH; Lu H; Zhang J; Li B
    Zhonghua Fu Chan Ke Za Zhi; 2013 Aug; 48(8):584-8. PubMed ID: 24199923
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Investigational drugs for endometriosis.
    Chlouber RO; Olive DL; Pritts EA
    Expert Opin Investig Drugs; 2006 Apr; 15(4):399-407. PubMed ID: 16548789
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Investigational drugs for the treatment of endometriosis, an update on recent developments.
    Barra F; Scala C; Mais V; Guerriero S; Ferrero S
    Expert Opin Investig Drugs; 2018 May; 27(5):445-458. PubMed ID: 29708812
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Current and Emerging Therapeutics for the Management of Endometriosis.
    Ferrero S; Barra F; Leone Roberti Maggiore U
    Drugs; 2018 Jul; 78(10):995-1012. PubMed ID: 29946962
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regression of the inflammatory microenvironment of the peritoneal cavity in women with endometriosis by GnRHa treatment.
    Nirgianakis K; Bersinger NA; McKinnon B; Kostov P; Imboden S; Mueller MD
    Eur J Obstet Gynecol Reprod Biol; 2013 Oct; 170(2):550-4. PubMed ID: 23993133
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endometriosis: translation of molecular insights to management.
    Langan KL; Farrell ME; Keyser EA; Salyer BA; Burney RO
    Minerva Endocrinol; 2014 Sep; 39(3):141-54. PubMed ID: 25003227
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A randomized study comparing the side effects and hormonal status of triptorelin and leuprorelin following conservative laparoscopic surgery for ovarian endometriosis in Chinese women.
    Li Z; Zhang HY; Zhu YJ; Hu YJ; Qu PP
    Eur J Obstet Gynecol Reprod Biol; 2014 Dec; 183():164-8. PubMed ID: 25461372
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Current and emerging treatment options for endometriosis.
    Ferrero S; Evangelisti G; Barra F
    Expert Opin Pharmacother; 2018 Jul; 19(10):1109-1125. PubMed ID: 29975553
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of pharmacotherapy in the treatment of endometriosis across the lifespan.
    Schwartz K; Llarena NC; Rehmer JM; Richards EG; Falcone T
    Expert Opin Pharmacother; 2020 Jun; 21(8):893-903. PubMed ID: 32164462
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Progesterone receptor modulators for endometriosis.
    Fu J; Song H; Zhou M; Zhu H; Wang Y; Chen H; Huang W
    Cochrane Database Syst Rev; 2017 Jul; 7(7):CD009881. PubMed ID: 28742263
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endometriosis is sustained by tumour necrosis factor-alpha.
    Bullimore DW
    Med Hypotheses; 2003 Jan; 60(1):84-8. PubMed ID: 12450770
    [TBL] [Abstract][Full Text] [Related]  

  • 20. From pathogenesis to clinical practice: Emerging medical treatments for endometriosis.
    Clemenza S; Sorbi F; Noci I; Capezzuoli T; Turrini I; Carriero C; Buffi N; Fambrini M; Petraglia F
    Best Pract Res Clin Obstet Gynaecol; 2018 Aug; 51():92-101. PubMed ID: 29559388
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.